Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?
about
Progressive familial intrahepatic cholestasisBile acid transportersBile acids: regulation of synthesisNuclear receptors: mediators and modifiers of inflammation-induced cholestasis.Bile formation and secretion.Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstructionNew perspectives for the treatment of cholestasis: lessons from basic science applied clinically.Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner.Prolonged cholestasis following hepatitis a virus infection: revisiting the role of steroids.New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout miceAlteration of canalicular transporters in a mouse model of total parenteral nutrition.Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
P2860
Q21202893-43B82366-D589-4954-A7D6-DA801811A6FBQ24652624-3619E4B1-8BA6-43CC-B5F6-85FC466A66B3Q24658139-6E7F178F-9DF5-47BB-A9CC-52589C35CE95Q33859400-86207C86-4FBC-446D-9406-A99E3281D7C8Q33881922-5F951DE2-871C-40D4-A50E-C5639B617469Q34017604-61E0046C-A09F-40AC-B092-608993E15557Q34024552-2ED536BE-F3E2-479D-BB10-2717B8B288C2Q34882162-C9ABDF03-2C96-42B5-A4BF-790B3380DA31Q35145151-26350CF5-3F89-44D9-9F85-3C4F493456C7Q35479252-4DFBC3A8-1F60-4D8B-8647-60AA76B0B076Q35583781-5EA32812-C6B6-4E3C-BD43-371EF3C24151Q35741546-EC61EBBB-92E5-4B8C-8FE8-E331A741B72AQ37200971-B852597F-9767-4D2E-A582-085BC4F53F95Q37250362-D4AC371B-05EC-4C1D-BFE8-FF2EEA59F747Q39871177-8BFB6183-9CC0-4641-B618-F0FB3D222881Q41822942-8BE66698-85AE-4779-AF0C-8A71EC9337EFQ42083872-513A445E-C754-4287-BB46-3EA7905C4167Q42089971-975FF150-6F08-4EB3-B651-E4083B64D15BQ47668921-8DBCD24F-7C10-4D9D-BD58-36D1166AD873
P2860
Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@ast
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@en
type
label
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@ast
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@en
prefLabel
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@ast
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@en
P1433
P1476
Nuclear receptor ligands: rati ...... nic cholestatic liver disease?
@en
P2093
James L Boyer
P304
P356
10.1053/J.GASTRO.2005.06.053
P407
P577
2005-08-01T00:00:00Z